Pfizer–BioNTech COVID-19 vaccine
Type of vaccine for humans
Pfizer–BioNTech COVID-19 vaccine ▸ Facts ▸ Comments ▸ News ▸ Videos
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with American company Pfizer to carry out clinical trials, logistics, and manufacturing. It is authorized for use in people to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus. The vaccine is given by intramuscular injection. It is composed of nucleoside-modified mRNA (modRNA) encoding a mutated form of the full-length spike protein of SARS-CoV-2, which is encapsulated in lipid nanoparticles. Initial advice indicated that vaccination required two doses given 21 days apart, but the interval was later extended to up to 42 days in the US, and up to four months in Canada.
0 shares | ShareTweetSavePostSend |
You Might Like
Covid-19: A wide range of vaccines act as booster to AstraZeneca, Pfizer shots, says studyUp to six different Covid-19 boosters were found to be safe, and provoked strong immune responses in people who have previously received a two-dose course of the Oxford-AstraZeneca-developed..IndiaTimes - Published | |
AstraZeneca and Pfizer safe to use as booster jabs, UK medicines regulator saysThe UK's medicines regulator has said the Pfizer-BioNTech and Oxford-AstraZeneca coronavirus vaccines are safe to use as booster jabs.Sky News - Published | |
Covishield becomes collateral damage in inter-EU tussle over Chinese vaccinesEMA has listed 4 vaccines, which are Comirnaty (Pfizer), Janssen, Spikevax (previously COVID-19 Vaccine Moderna), and AstraZeneca's Vaxzevria.DNA - Published | |
Search this site and the web: |